Adjunctive therapy with eptifibatide administered as a double bolus plus infusion in a patient undergoing elective implantation of a coronary stent.
Gruberg
L
L
Cardiovascular Research Institute, 110 Irving Street, Suite 4B1, Washington, DC 20010, USA.
Satler
L F
LF
D000368:Aged; D017024:Chemotherapy, Adjuvant; D017023:Coronary Angiography; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017558:Elective Surgical Procedures; D000077542:Eptifibatide; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D015425:Myocardial Reperfusion / Q000295:instrumentation* / Q000379:methods; D010455:Peptides / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D012720:Severity of Illness Index; D015607:Stents; D016896:Treatment Outcome
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide